Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Oct 8th, 4:41 AM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | N/A - N/A |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
Denver, CO – October 7, 2025 – Solid Power, Inc. (NASDAQ: SLDP), a leading developer of all-solid-state battery technology, has reached a new 52-week high today, with its stock trading as high as $6.30 and closing at $6.33. This significant milestone underscores growing investor confidence in the company's groundbreaking advancements
Via MarketMinute · October 7, 2025
Munich, Germany – October 7, 2025 – Luxury automotive giant Bayerische Motoren Werke AG (BWM.DE) (BMWYY) has delivered a sobering outlook for the coming year, announcing a significant cut to its 2025 earnings forecast. The revised projections, revealed today, paint a picture of increased caution, primarily driven by a protracted slowdown
Via MarketMinute · October 7, 2025
Louisville, CO – October 7, 2025 – Solid Power (NASDAQ: SLDP), a leading developer of all-solid-state battery technology, has reached an impressive new 52-week high, with shares trading as high as $6.30 today. This significant surge in stock price reflects growing investor confidence and market optimism surrounding the company's continuous advancements
Via MarketMinute · October 7, 2025
The University of Waterloo has unveiled a groundbreaking AI-radar system poised to redefine remote health monitoring and early disease detection. This innovative, non-invasive technology tracks subtle changes in a patient's walk and other vital signs, offering an unprecedented "invisible safety net" for individuals, particularly in vulnerable populations and busy healthcare settings. By leveraging advanced radar [...]
Via TokenRing AI · October 7, 2025
Lund University Researchers Discover Why Leukemia Cells Evade the Immune System
While immunotherapy has scored a significant level of success in treating many types of cancer, it hasn’t registered similar efficacy in leukemia, especially acute myeloid leukemia, also known as AML. Researchers at Lund University, Sweden have found a possible reason why this could be so.
Via Investor Brand Network · October 7, 2025
October 6, 2025 - The global financial landscape is currently grappling with a significant shift as both the Euro and the Japanese Yen show signs of considerable weakening. While specific real-time events on this future date cannot be predicted, an analysis of ongoing economic trends and expert forecasts suggests that
Via MarketMinute · October 6, 2025
Clarksville, TN – October 4, 2025 – Microvast Holdings, Inc. (NASDAQ: MVST), a leading innovator in battery technology, has captured significant market attention by achieving a new 52-week high, reaching as high as $4.91, marking an impressive 1844.09% increase over the past year. This surge signals robust investor confidence and
Via MarketMinute · October 4, 2025
Shares of carbonate fuel cell technology developer FuelCell Energy (NASDAQ:FCEL)
jumped 16.3% in the afternoon session after the hydrogen fuel cell sector experienced a surge in positive sentiment after an analyst at H.C. Wainwright more than doubled the price target for industry peer Plug Power.
Via StockStory · October 3, 2025
Why Health Insurance Credits Led to the Federal Government Shutdown
Lawmakers in the U.S. Congress hit a stalemate in talks to keep the government open and on Wednesday, a shutdown commenced. At the core of the disagreement between GOP lawmakers and their Democratic Party counterparts are the health care tax credits in the Affordable Care Act due to expire at the end of this year and which the Big Beautiful Bill’s provisions don’t include an extension to these tax credits.
Via Investor Brand Network · October 3, 2025
The automotive industry is undergoing an unprecedented transformation, driven by the rapid global adoption of electric vehicles (EVs) and the relentless march towards fully autonomous driving. This profound shift has ignited an insatiable demand for highly specialized semiconductors, fundamentally repositioning the automotive sector as a primary growth engine for the chip industry. Vehicles are evolving [...]
Via TokenRing AI · October 4, 2025
Tesla (NASDAQ: TSLA) has once again captured headlines with its robust third-quarter 2025 delivery performance, reporting record global vehicle deliveries that comfortably surpassed analyst estimates. This surge was primarily driven by an aggressive pull-forward of demand in the United States, as consumers rushed to capitalize on the expiring federal EV
Via MarketMinute · October 2, 2025
On October 2nd, 2025, electric vehicle giant Tesla (NASDAQ: TSLA) announced an unprecedented third quarter for vehicle deliveries, significantly surpassing even the most optimistic projections from Wall Street. This remarkable achievement immediately triggered a substantial rally in Tesla's stock, sending shares to new 2025 highs and pushing the company's market
Via MarketMinute · October 2, 2025
Rapid Spread of ‘Nightmare Bacteria’ Triggers Alarm
In 2013, former CDC director Tom Frieden observed that there were rising cases of ‘nightmare bacteria’, a category of bacteria characterized by three deadly attributes; resistance to all or almost all antibiotics, high mortality levels, and their ability to spread antibiotic resistance to other types of bacteria. From this triple threat of these microbes, one can understand why they are described as ‘nightmare bacteria.’ Data shows that cases of these bacteria are increasing at an alarming rate in the U.S.
Via Investor Brand Network · October 2, 2025
The nascent DePIN (Decentralized Physical Infrastructure Networks) sector has a new focal point in PEAQ ($PEAQ), a Layer 1 blockchain that burst onto the scene with its Token Generation Event (TGE) in September 2024. Following an initial public sale on CoinList in May 2024 and subsequent listings on major exchanges around November 2024, PEAQ witnessed [...]
Via BreakingCrypto · October 1, 2025
Oncotelic Therapeutics Inc. (OTLC) Venture Sapu Nano Receives Approval to Begin Human Clinical Trials of Sapu003, an Injectible Form of Afinitor(R) (Everolimus) for Breast Cancer Treatment
Sapu Nano, part of a group of companies formed through GMP Biotechnology Limited, which is a joint venture between Oncotelic Therapeutics (OTCQB: OTLC) and Dragon Overseas Capital Limited, recently received approval from the HREC in Australia to begin enrolling people in clinical trails of Sapu003 for the treatment of breast cancer.
Via Investor Brand Network · October 1, 2025
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development
Hoth Therapeutics (NASDAQ: HOTH), a biopharmaceutical company, recently announced that the company is using an AI-powered platform developed by Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotech company and pharma, to streamline and improve the drug development process ( https://ibn.fm/VIL67 ).
Via Investor Brand Network · October 1, 2025
Scorpion Venom Shows Promise in Brain Tumor Treatment
The sight of a scorpion moving towards you with its stinger raised can send a chill down the spine of the bravest among us. If you watched Fear Factor, you saw how terrified the contestants were to come face to face with these creatures. While scorpions have been portrayed as the stuff of nightmares, scientists have found that they can be useful in the fight against brain cancer .
Via Investor Brand Network · September 30, 2025
On September 27, the World New Energy Vehicle Development Organization (WNEVDO) was officially established.
Via Get News · September 29, 2025
Soligenix Inc. (NASDAQ: SNGX) Advances Psoriasis Trial with Encouraging Patient Results, Market Potential
Psoriasis remains a persistent challenge for millions of patients worldwide, and promising new treatments are being closely watched by the medical and investor communities alike. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and inflammatory conditions, is advancing its treatment candidate, SGX302, in a phase 2a clinical trial for mild-to-moderate psoriasis. The company has already seen encouraging signals in earlier proof-of-concept work, and with its current study underway, Soligenix is positioning itself to expand its presence in dermatology with a novel therapeutic option for one of the most prevalent autoimmune skin conditions.
Via Investor Brand Network · September 29, 2025
Munich, Bavaria, Germany, September 29, 2025 -- On September 11-12, 2025, the 2nd Europe-China New Energy Vehicle Technology Conference was held in Munich, Germany. Dr. Richard Zhang, Managing Director of EVE Germany, attended and delivered a keynote speech titled "Rooted in Europe, Symbiosis and Growth." The speech outlined EVE Energy's business strategies in Europe and achievements in technological innovation, localized production, and sustainable development.
Via Press Release Distribution Service · September 29, 2025
Lucid's progress has been slow over the past several years. While production has gained some momentum recently, it's not enough to offset the company's losses.
Via The Motley Fool · September 28, 2025
In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a growing consensus: patients, providers, and regulators all want sharper images with lower radiation exposure.
Via Investor Brand Network · September 26, 2025
Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis
Groundbreaking research presented at the ECTRIMS 2025 conference held in Barcelona, Spain provides new insights into the ways in which menopause impacts the health implications and clinical manifestations in women who have multiple sclerosis. This study shows that changes in hormones influence the initial symptoms experienced by women with MS and also play a role in the comorbidities suffered by the affected individuals.
Via Investor Brand Network · September 26, 2025
German automaker BMW of North America LLC has issued a recall of over 196,355 units of its vehicles in the U.S. over a starter defect that can become a potential fire hazard.
Via Benzinga · September 26, 2025
September 25, 2025 – Tesla (NASDAQ: TSLA) shares experienced a notable decline today, trading lower amid broader market weakness and specific concerns stemming from a significant slump in its European sales performance. This downturn, which saw TSLA shares drop by over 3% to 4% throughout the day, trading around $424.54
Via MarketMinute · September 25, 2025